These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22082579)

  • 21. Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study.
    Bruining N; de Winter S; Roelandt JR; Regar E; Heller I; van Domburg RT; Hamers R; Onuma Y; Dudek D; Webster MW; Thuesen L; Ormiston JA; Cheong WF; Miquel-Hebert K; Veldhof S; Serruys PW
    JACC Cardiovasc Interv; 2010 Apr; 3(4):449-56. PubMed ID: 20398874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents.
    Denardo SJ; Carpinone PL; Vock DM; Tcheng JE; Phillips HR; Willenberg BJ; Batich CD; Pepine CJ
    EuroIntervention; 2013 Jul; 9(3):389-97. PubMed ID: 23872653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating.
    Jabara R; Chronos N; Conway D; Molema W; Robinson K
    JACC Cardiovasc Interv; 2008 Feb; 1(1):81-7. PubMed ID: 19393150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial Effects of a Novel Bioabsorbable Polymer Coating on Enhanced Coronary Vasoconstricting Responses After Drug-Eluting Stent Implantation in Pigs in Vivo.
    Nishimiya K; Matsumoto Y; Uzuka H; Ogata T; Hirano M; Shindo T; Hasebe Y; Tsuburaya R; Shiroto T; Takahashi J; Ito K; Shimokawa H
    JACC Cardiovasc Interv; 2016 Feb; 9(3):281-291. PubMed ID: 26847120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
    Jabara R; Chronos N; Robinson K
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation.
    Murata A; Wallace-Bradley D; Tellez A; Alviar C; Aboodi M; Sheehy A; Coleman L; Perkins L; Nakazawa G; Mintz G; Kaluza GL; Virmani R; Granada JF
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):76-84. PubMed ID: 20129535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting stents in bifurcations: bench study of strut deformation and coating lesions.
    Guérin P; Pilet P; Finet G; Gouëffic Y; N'Guyen JM; Crochet D; Tijou I; Pacaud P; Loirand G
    Circ Cardiovasc Interv; 2010 Apr; 3(2):120-6. PubMed ID: 20197512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions).
    Garg S; Serruys P; Onuma Y; Dorange C; Veldhof S; Miquel-Hébert K; Sudhir K; Boland J; Huber K; Garcia E; te Riele JA;
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1190-8. PubMed ID: 20129545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
    Christiansen EH; Jensen LO; Thayssen P; Tilsted HH; Krusell LR; Hansen KN; Kaltoft A; Maeng M; Kristensen SD; Bøtker HE; Terkelsen CJ; Villadsen AB; Ravkilde J; Aarøe J; Madsen M; Thuesen L; Lassen JF;
    Lancet; 2013 Feb; 381(9867):661-9. PubMed ID: 23374649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings.
    Lockwood NA; Hergenrother RW; Patrick LM; Stucke SM; Steendam R; Pacheco E; Virmani R; Kolodgie FD; Hubbard B
    J Biomater Sci Polym Ed; 2010; 21(4):529-52. PubMed ID: 20233507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of balloon withdrawal forces with bare-metal stents, compared with Taxus and Cypher drug-eluting coronary stents: balloon, stent and polymer interactions.
    Turk M; Gupta V; Fischell TA
    J Invasive Cardiol; 2010 Mar; 22(3):113-6. PubMed ID: 20197577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scanning electron microscopic analysis of different drug eluting stents after failed implantation: from nearly undamaged to major damaged polymers.
    Wiemer M; Butz T; Schmidt W; Schmitz KP; Horstkotte D; Langer C
    Catheter Cardiovasc Interv; 2010 May; 75(6):905-11. PubMed ID: 20088011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.
    Byrne RA; Kastrati A; Massberg S; Wieczorek A; Laugwitz KL; Hadamitzky M; Schulz S; Pache J; Fusaro M; Hausleiter J; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2011 Sep; 58(13):1325-31. PubMed ID: 21920260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient coronary aneurysm formation after Nevo™ stent implantation versus persistent coronary aneurysm after Cypher Select™ stent implantation.
    Christiansen EH; Lassen JF; Jensen LO
    J Invasive Cardiol; 2011 Jul; 23(7):E158-60. PubMed ID: 21725130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents.
    Otsuka Y; Chronos NA; Apkarian RP; Robinson KA
    J Invasive Cardiol; 2007 Feb; 19(2):71-6. PubMed ID: 17268041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the SYNERGY with the PROMUS (XIENCE V) and bare metal and polymer-only Element control stents in porcine coronary arteries.
    Wilson GJ; Huibregtse BA; Pennington DE; Dawkins KD
    EuroIntervention; 2012 Jun; 8(2):250-7. PubMed ID: 22717928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial.
    Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE
    EuroIntervention; 2012 May; 8(1):117-9. PubMed ID: 22580255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.